Surgery – Miscellaneous – Methods
Patent
1996-10-11
1998-05-05
Millin, V.
Surgery
Miscellaneous
Methods
604 49, A61B 1900
Patent
active
057462232
ABSTRACT:
A pharmaceutical composition, kit, and method of forcing the reverse transport of cholesterol from peripheral tissues to the liver in vivo while controlling plasma LDL concentrations is provided. The method includes the step of administering a therapeutically effective amount of a multiplicity of large liposomes comprised of phospholipids substantially free of sterol for a treatment period. The method optionally includes the step of periodically assaying plasma LDL concentrations with an assay during the treatment period to assess plasma atherogenic lipoprotein concentrations and obtain an atherogenic lipoprotein profile, and adjusting the administration in response to the profile. The large liposomes are dimensioned larger than fenestrations of an endothelial layer lining hepatic sinusoids in the liver so that the liposomes are too large to readily penetrate the fenestrations. The therapeutically effective amounts are in the range of about 10 mg to about 1600 mg phospholipid per kg body weight per dose. A pharmaceutical composition and related kit for mobilizing peripheral cholesterol and sphingomyelin that enters the liver of a subject consisting essentially of liposomes of a size and shape larger than fenestrations of an endothelial layer lining hepatic sinusoids in the liver is also provided.
REFERENCES:
patent: 5077056 (1991-12-01), Bally et al.
patent: 5204112 (1993-04-01), Hope et al.
patent: 5252263 (1993-10-01), Hope et al.
patent: 5376452 (1994-12-01), Hope et al.
Williams et al. "Intravaneously Administered Lecithin Liposomes" Pespect Biol Mes (USA) 27(3):417-31, May 1984.
Williams et al. "Lipoprotein X Contains Apoe and is Recognized by Fibroblast B:E Receptor" Arteriosclerosis 5(5):507A, Sep. 1985.
Williams et al. "Recognition of Vesicular Lipoproteins by the Apolipoprotein B,E Receptor of Cultured Fibroblasts" J Lipid Res 27(8):892-900, 1986.
Williams et al. "Uptake of Endogenous Cholesterol by a Synthetic Lipoprotein" Biochim Biophys Acta (Netherlands) 875(2):183-94, 1986.
Williams et al. "Phospholipid Liposomes Acquire Apolipoprotein E in Atherogenic Plasma and Inhibit Cholesterol Loading of Macrophages." AM Heart Assoc Part 2, 74(4) Monogr (124) 11-197, 1986.
Bisgaier et al. "Effect of Lecithin:Cholesterol Acyltransferase on Distribution of Apolipoprotein A-IV Among Lipoproteins of Human Plasma," J Lipid Res 28(6):693-703, 1987.
Williams et al. "LDL Receptor-Independent Hepatic Uptake of Synthetic Cholesterol-Scavenging Particle." Arteriosclerosis 7(5):496A, 1987.
Aviram et al. "Intralipid Infusion Abolishes the Ability of Human Serum to Cholesterol -Load Cultured Macrophages." Arteriosclerosis 7(5):547A-548A, 1987.
Williams et al. "Phospholipid Liposomes Acquire Apolipoprotein E in Atherogenic Plasma and Block Cholesterol Loading of Cultured Macrophages." J Clin Invest 79(5):1466-72, 1987.
Aviram et al. "Macrophage Cholesterol Removal by Triglyceride-Phospholipid Emulsions." Biochem Biophys Res Commun (USA) 155(2):709-13, 1988.
Williams et al. "Low Density Lipoprotein Receptor-Independent Hepatic Uptake of a Synthetic, Cholesterol-Scavenging Lipoprotein." Natl Acad Sci USA 85(1):242-6, 1988.
Aviram et al. "Intralipid Infusion Abolishes Ability of Human Serum to Cholesterol-Load Cultured Macrophages." Arteriosclerosis 9(1):67-75, Jan. 1989.
Masana et al. "Treatment of Diet-Resistant Polygenic Hypercholesterolaemic Patients With a New Nicotinate Derivative" J Clin Pharmacol 29(3):201-6, Mar. 1989.
Weinberg et al. "Short-Term Parenteral Nutrition with Glucose and Intralipid(R)." Am J Clin Nutr 49(5):794-8, May 1989.
Manzoni et al. "Differential Effects of Beclobrate on Lipid/Lipoprotein Distribution in Normal and Hypercholesterolemic Rats." Eur J Pharmacol 190(1-2):39-49, Nov. 1990.
Nakashima et al. "Effects of Polysulphated Glycosaminoglycans Obtained from Bovine Lung Tissue on Hypercholesterolemic Rabbits." Artery 17(5):248-70, 1990.
Shimano et al. "Plasma Cholesterol-Lowering Activity of Monocyte Colony-Stimulating Factor (M-CSF)," Ann NY Acad Sci (USA) 587:362-70, 1990.
Voet and Voet "Biochemistry" Chapter 23, pp. 645-656, 1990.
Jay et al. "Effects of Pravastatin and Cholestyramine on Gonadal and Adrenal Steriod Production in Familial Hypercholesterolaemia." Br J Clin Pharmacol 32(4):417-422, Oct. 1991.
Kanazawa et al. "Effects of Low-Density Lipoprotein from Normal Rabbits on Hypercholesterolemia and the Development of Atherosclerosis." Pathobiology (Swiss) 59(2):85-91, 1991.
Williams et al. "Smooth Muscle Cell-Dependent LDL Aggregation a Possible Mechanism for LDL Retention and Foam Cell Formation." Circulation 86(4 Suppl. 1):1475, Nov. 1992.
Stevenson et al. "Phenotypic Correction of Hypercholesterolemia in Apoe-Deficient Mice by Adenovirus-Mediated In Vivo Gene Transfer." Arterioscler Thromb Vasc Biol 15(4):479-84, Apr. 1995.
Rodrigueza et al. "Large Versus Small Unilamellar Vesicles Mediate Reverse Cholesterol Transport In Vivo into Two Distinct Hepatic Metabolic Pools." Circulation 92(8 Suppl.) 1556, Nov. 1995.
Millin V.
O'Hara Kelly
LandOfFree
Method of forcing the reverse transport of cholesterol from a bo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of forcing the reverse transport of cholesterol from a bo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of forcing the reverse transport of cholesterol from a bo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-46184